Related Experiment Video
Updated: Dec 6, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Circular RNA CircCDH13 contributes to the pathogenesis of osteoarthritis via CircCDH13/miR-296-3p/PTEN axis
Zhibin Zhou1, Jun Ma2, Jiajia Lu2
1Department of Orthopaedics, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Insights
Circular RNAs (circRNAs) like CircCDH13 are upregulated in osteoarthritis (OA), driving disease progression by promoting chondrocyte apoptosis and matrix degradation. Silencing CircCDH13 offers a potential therapeutic strategy for OA treatment.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are implicated in various human diseases, but their role in osteoarthritis (OA) is not well understood.
- Osteoarthritis (OA) is a degenerative joint disease characterized by cartilage breakdown and inflammation.
Purpose of the Study:
- To investigate the role and underlying mechanisms of CircCDH13 in the pathogenesis of osteoarthritis (OA).
- To explore CircCDH13 as a potential therapeutic target for OA.
Main Methods:
- Microarray analysis to detect circRNA expression profiles in OA and normal cartilage.
- In vitro and in vivo experiments using gain-of-function and loss-of-function approaches.
- Bioinformatics prediction, RNA pulldown, luciferase assays, and adeno-associated virus (AAV) delivery in a mouse model of OA.
Main Results:
- CircCDH13 was significantly upregulated in OA cartilage tissues.
- CircCDH13 promoted chondrocyte apoptosis, extracellular matrix (ECM) catabolism, and inhibited ECM anabolism in OA.
- CircCDH13 acted as a molecular sponge for miR-296-3p, regulating the miR-296-3p-PTEN pathway.
- In vivo silencing of CircCDH13 alleviated destabilization of medial meniscus (DMM)-induced OA in mice.
Conclusions:
- CircCDH13 plays a critical role in OA pathogenesis by modulating chondrocyte apoptosis and ECM homeostasis via the miR-296-3p-PTEN axis.
- Targeting CircCDH13 presents a promising therapeutic avenue for OA intervention.
Abstract:
Circular RNAs (circRNAs) are involved in a variety of human diseases; however, the function of circRNAs in osteoarthritis (OA) remains largely unknown. In this study, we investigated the role of CircCDH13 in OA and its underlying mechanisms. CircRNA expression profiles in OA and normal cartilage tissues were detected by microarray. The expression pattern, functional role, and mechanisms of CircCDH13 in OA were studied in vitro and in vivo. Gain-of-function and loss-of-function approaches were used to demonstrate the participation of CircCDH13 in OA. The regulatory relationship between CircCDH13 and miR-296-3p and miR-296-3p and phosphatase and tensin homolog (PTEN) was predicted by bioinformatics and verified by RNA pulldown and luciferase assay. Adeno-associated virus was also used to reveal the role and mechanisms of CircCDH13 in destabilization of medial meniscus (DMM)-induced OA mice. The upregulation of CircCDH13 in OA cartilage tissues significantly induces chondrocyte apoptosis, promotes extracellular matrix (ECM) catabolism, and inhibits ECM anabolism. Mechanistically, CircCDH13 contributes to OA pathogenesis by functioning as a sponge of miR-296-3p and regulating the miR-296-3p-PTEN pathway. Silencing of CircCDH13 in vivo markedly alleviated DMM-induced OA in mice. Our study revealed an important role of CircCDH13 in OA pathogenesis. Silencing of CircCDH13 could reduce chondrocyte apoptosis, inhibit ECM catabolism, and promote ECM anabolism through the miR-296-3p-PTEN pathway. It provides a potential target for developing effective interventions in treating OA.
Related Concept Videos
The JAK-STAT Signaling Pathway
Experimental RNAi
TGF - β Signaling Pathway
piRNA - Piwi-interacting RNAs
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
RNA Editing

